XML 25 R26.htm IDEA: XBRL DOCUMENT
v2.4.0.8

2. DERIVATIVES LIABILITIES, WARRANTS AND OTHER OPTIONS (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative liabilities, warrants and other options outstanding |
Warrant | Issue Date |  | Shares Issuable upon Exercise of Warrant |  |  | Exercise Price |  | Expiration Date |  | Reference |
Series N | 8/18/08 |  |  | 518,771 |  |  |  | 3.00 |  | 8/18/14 |  |  | 1 |
Series A | 6/24/09 |  |  | 130,347 |  |  |  | 5.00 |  | 12/24/14 |  |  | 1 |
Schleuning (Series A) | 7/8/09 |  |  | 16,750 |  |  |  | 5.00 |  | 01/8/15 |  |  | 1 |
Series B | 9/4/09 |  |  | 50,000 |  |  |  | 6.80 |  | 9/4/14 |  |  | 1 |
Series C | 8/20/09 -8/26/09 |  |  | 463,487 |  |  |  | 5.50 |  | 2/20/15 |  |  | 1 |
Series E | 9/21/09 |  |  | 71,428 |  |  |  | 17.50 |  | 8/12/14 |  |  | 1 |
Series F | 10/6/11 |  |  | 1,200,000 |  |  |  | 4.00 |  | 10/6/14 |  |  | 1 |
Series G | 10/6/11 |  |  | 66,667 |  |  |  | 4.00 |  | 8/12/14 |  |  | 1 |
Series H | 1/26/12 |  |  | 1,200,000 |  |  |  | 5.00 |  | 8/1/15 |  |  | 1 |
Series Q | 6/21/12 |  |  | 1,200,000 |  |  |  | 5.00 |  | 12/22/15 |  |  | 1 |
Series R | 12/6/12 |  |  | 2,625,000 |  |  |  | 4.00 |  | 12/6/16 |  |  | 1 |
Series L | 4/18/07 |  |  | 25,000 |  |  |  | 7.50 |  | 4/17/14 |  |  | 2 |
Series L (repriced) | 4/18/07 |  |  | 70,000 |  |  |  | 2.50 |  | 4/2/15 |  |  | 2 |
Series M (modified) | 4/18/07 |  |  | 600,000 |  |  |  | 3.40 |  | 7/31/14 |  |  | 2 |
Series P | 2/10/12 |  |  | 590,001 |  |  |  | 4.50 |  | 3/6/17 |  |  | 3 |
Private Investors | 7/18/05 -6/30/09 |  |  | 740,938 |  |  |  | 5.60 – 8.20 |  | 1/26/14 - 7/18/14 |  |  | 4 |
Warrants held by Officer and Director | 6/24/09- 7/6/09 |  |  | 349,754 |  |  |  | 4.00 – 5.00 |  | 12/24/14 - 1/6/15 |  |  | 5 |
Consultants | 2/15/05 – 12/28/12 |  |  | 140,750 |  |  |  | 2.80 – 20.00 |  | 5/20/14 - 12/27/17 |  |  | 6 |
Derivative Liabilities |
|  | September 30, 2013 |  |  | September 30, 2012 |
Series A through E |  | $ | 6,106 |  |  | $ | 786,989 |
Series N |  |  | 41,501 |  |  |  | 830,034 |
Series F and G warrants |  |  | 12,667 |  |  |  | 1,646,667 |
Series H warrants |  |  | 36,000 |  |  |  | 1,800,000 |
Series Q warrants |  |  | 48,000 |  |  |  | 1,920,000 |
Series R warrants |  |  | 288,750 |  |  |  | - |
Total derivative liabilities |  | $ | 433,024 |  |  | $ | 6,983,690 |

X
- Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instruments that require the entity to deliver shares as part of a physical settlement or a net-share settlement or contracts that give the company a choice of (a) net-cash settlement or settlement in shares including net-share settlement or physical settlement that requires the company to deliver shares), or (b) net-share settlement or physical settlement that requires the company to deliver cash. In the case of an option contract indexed to the issuer's equity, this disclosure includes the option strike price, the number of issuer's shares to which the contract is indexed, the settlement date or dates of the contract, and the issuer's accounting for the contract (i.e., asset, liability, or equity). Also includes description of the settlement alternatives, who controls the settlement alternatives, and the maximum number of shares that could be required to be issued to net-share settle the contract. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclosure includes the contract's current fair value of settlement alternatives (in monetary or quantities of shares) and how changes in the price of the issuer's equity instruments affect those settlement amounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90193-114008 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90198-114008 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008 + Details
Name: | us-gaap_ScheduleOfDerivativeFinancialInstrumentsIndexedToAndPotentiallySettledInEntitysOwnStockEquityTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration